Loading...
You are here:  Home  >  News  >  Business  >  Current Article

Bristol Myers Squibb and Celgene Issue Notices of Redemption and Partial Redemption of Certain of Their Senior Notes at “Make Whole” Prices

By   /  February 23, 2021  /  No Comments

    Print       Email


NEW YORK–()–Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol Myers Squibb”) issued a notice of redemption to The Bank of New York Mellon (successor to The Chase Manhattan Bank (National Association)), as trustee, to redeem (i) all of Bristol Myers Squibb’s 4.000% Notes due 2023 (CUSIP/ISIN Nos. 110122DA3/110122BL1/U11009AL8), originally issued on November 22, 2019, that remain outstanding after the early settlement of the previously announced tender offers (the “BMS 4.000% Notes”) and (ii) $42,250,000 principal amount of $932,101,000 principal amount of Bristol Myers Squibb’s outstanding 3.250% Notes due 2023 (CUSIP/ISIN Nos. 110122BK3/U11009AK0/110122CZ9), originally issued on November 22, 2019 (the…



Click here to view the original article.

    Print       Email

You might also like...

Riassunto: Riflettori puntati sull’eccellenza nei sistemi sanitari e scolastici in Cina nel corso delle “Due sessioni”

Read More →